Literature DB >> 34632534

Circ_0069718 promotes the progression of breast cancer by up-regulating NFIB through sequestering miR-590-5p.

Yongsheng Zhao1, Xiaocha Ma1, Weihua Shi2.   

Abstract

Researches indicate that circular RNAs are dysregulated in breast cancer (BC) and play a critical role in regulating the malignant phenotype of cancer cells. Herein, the goal of this work was to investigate the role and mechanism of circ_0069718 in BC development. Levels of genes and proteins were detected by quantitative real-time polymerase chain reaction and western blot. In vitro experiments were performed using cell counting kit-8 assay, colony formation assay, EdU (5-ethynyl-2'-deoxyuridine) assay, flow cytometry, western blot, and transwell assay, respectively. The dual-luciferase reporter and RNA immunoprecipitation assays were used to identify the target relationship between miR-590-5p and circ_0069718 or nuclear factor I/B (NFIB). In vivo experiments were conducted using Xenograft model in mice. Circ_0069718 was up-regulated in BC tissues and cells. Knockdown of circ_0069718 suppressed BC cell apoptosis, migration, and invasion in vitro effectively. Mechanistically, circ_0069718 directly targeted miR-590-5p to up-regulate its target NFIB. Rescue experiments showed that miR-590-5p inhibition reversed the inhibitory effects of circ_0069718 knockdown on BC cell-aggressive oncogenic phenotypes; moreover, miR-590-5p re-expression restrained BC cell proliferation and mobility, which were abolished by NFIB up-regulation. Besides that, circ_0069718 silencing hindered tumor growth via miR-590-5p/NFIB axis in vivo. Circ_0069718 promotes BC progression by up-regulating NFIB through sequestering miR-590-5p, suggesting a potential therapeutic strategy in BC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34632534     DOI: 10.1007/s00335-021-09923-y

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  7 in total

1.  CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.

Authors:  J Zhang; H-D Xu; X-J Xing; Z-T Liang; Z-H Xia; Y Zhao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-06       Impact factor: 3.507

2.  miR-590-5p promotes liver cancer growth and chemotherapy resistance through directly targeting FOXO1.

Authors:  Guiqing Jia; Youyin Tang; Gang Deng; Dan Fang; Jie Xie; Lvnan Yan; Zheyu Chen
Journal:  Am J Transl Res       Date:  2019-04-15       Impact factor: 4.060

3.  circRNA‑CER mediates malignant progression of breast cancer through targeting the miR‑136/MMP13 axis.

Authors:  Yikun Qu; Penghui Dou; Ming Hu; Jian Xu; Weibin Xia; Hongmei Sun
Journal:  Mol Med Rep       Date:  2019-02-18       Impact factor: 2.952

4.  miR‑590‑5p suppresses osteosarcoma cell proliferation and invasion via targeting KLF5.

Authors:  Wei Cai; Yong Xu; Jian Yin; Wenshan Zuo; Zhen Su
Journal:  Mol Med Rep       Date:  2018-06-15       Impact factor: 2.952

5.  MicroRNA miR-590-5p inhibits breast cancer cell stemness and metastasis by targeting SOX2.

Authors:  L Zhou; L-C Zhao; N Jiang; X-L Wang; X-N Zhou; X-L Luo; J Ren
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-01       Impact factor: 3.507

6.  MicroRNA-590-5p suppresses the proliferation and invasion of non-small cell lung cancer by regulating GAB1.

Authors:  B-B Xu; Z-F Gu; M Ma; J-Y Wang; H-N Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-09       Impact factor: 3.507

7.  miR‑590‑5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression.

Authors:  Kuanhou Mou; Meiling Ding; Dan Han; Yan Zhou; Xin Mu; Wenli Liu; Lijuan Wang
Journal:  Oncol Rep       Date:  2018-08-07       Impact factor: 3.906

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.